WAT - Waters Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
214.80
-0.01 (-0.00%)
As of 2:56PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close214.81
Open215.66
Bid214.87 x 800
Ask214.96 x 800
Day's Range214.74 - 217.00
52 Week Range167.94 - 255.21
Volume330,221
Avg. Volume656,653
Market Cap14.923B
Beta (3Y Monthly)1.08
PE Ratio (TTM)27.52
EPS (TTM)7.80
Earnings DateJul 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1996-11-26
1y Target Est212.15
Trade prices are not sourced from all markets
  • When Should You Buy Waters Corporation (NYSE:WAT)?
    Simply Wall St.yesterday

    When Should You Buy Waters Corporation (NYSE:WAT)?

    Waters Corporation (NYSE:WAT) saw significant share price movement during recent months on the NYSE, rising to highs...

  • Business Wire16 days ago

    Waters Corporation Q2 2019 Financial Results Webcast Invitation

    Waters Corporation will webcast its Q2 2019 financial results conference call live on Tuesday, July 30th at 8:00 a.m. eastern time. To listen to the conference call connect to Waters’ website, www.waters.com choose “Investors” and click on the Live Webcast.

  • Should You Be Worried About Insider Transactions At Waters Corporation (NYSE:WAT)?
    Simply Wall St.last month

    Should You Be Worried About Insider Transactions At Waters Corporation (NYSE:WAT)?

    We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

  • PR Newswirelast month

    Human Glycome Project Boosted by Support of Critical Goods and Services from Genos, New England Biolabs and Waters Corporation

    ZAGREB, Croatia and IPSWICH, Mass. and MILFORD, Mass., June 17, 2019 /PRNewswire/ -- The Human Glycome Project,  Genos®, New England Biolabs® (NEB®) and Waters™ Corporation today announced a collaboration to accelerate glycomics research by providing goods and services critical to glycan analysis. Launched in October 2018, the Human Glycome Project is a global initiative to map the structure and function of human glycans. The completion of the human genome project opened multiple new opportunities to study and understand human health, but it also led to the realization that the genome is only one of the elements that controls life.

  • Here’s What Hedge Funds Think About Waters Corporation (WAT)
    Insider Monkeylast month

    Here’s What Hedge Funds Think About Waters Corporation (WAT)

    We at Insider Monkey have gone over 738 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st. In this article, we look at what those funds think of Waters Corporation (NYSE:WAT) based on that data. […]

  • Markitlast month

    See what the IHS Markit Score report has to say about Waters Corp.

    Waters Corp NYSE:WATView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is low for WAT with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding WAT totaled $5.67 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers’ Index (PMI) data, output in the Industrialsis falling. The rate of decline is very significant relative to the trend shown over the past year, and is accelerating. The rate of contraction may ease in the coming months, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of WAT earnings conference call or presentation 23-Apr-19 12:00pm GMT

    Q1 2019 Waters Corp Earnings Call

  • Waters Novel Cyclic IMS and New SYNAPT XS Lead Full Portfolio of Mass Spectrometry Innovations at ASMS
    Business Wire2 months ago

    Waters Novel Cyclic IMS and New SYNAPT XS Lead Full Portfolio of Mass Spectrometry Innovations at ASMS

    First-of-its-Kind Cyclic IMS Provides Unlimited Experimental Opportunities while the Research-Grade SYNAPT XS Brings Analytical Flexibility

  • Waters (WAT) Down 0.1% Since Last Earnings Report: Can It Rebound?
    Zacks2 months ago

    Waters (WAT) Down 0.1% Since Last Earnings Report: Can It Rebound?

    Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Is Waters Corporation (NYSE:WAT) Expensive For A Reason? A Look At Its Intrinsic Value
    Simply Wall St.2 months ago

    Is Waters Corporation (NYSE:WAT) Expensive For A Reason? A Look At Its Intrinsic Value

    Does the May share price for Waters Corporation (NYSE:WAT) reflect what it's really worth? Today, we will estimate the...

  • Business Wire2 months ago

    Waters Corporation Presentation at the UBS Global Healthcare Conference to Be Webcast Live

    Waters Corporation Chris O'Connell, Chairman and Chief Executive Officer, will speak to the investment community at the UBS Global Healthcare Conference to be held at the Grand Hyatt New York, Monday, May 20th at 2:00 PM eastern time.

  • This Medical Supplier Toppled Below A Breakout On Its Earnings Lag
    Investor's Business Daily3 months ago

    This Medical Supplier Toppled Below A Breakout On Its Earnings Lag

    Shares of Waters Corporation plunged Tuesday after the medical supplier's first-quarter revenue and earnings widely lagged Wall Street estimates. Waters also cut its full-year forecast.

  • Why Fiat Chrysler Automobiles, Waters, and Astec Industries Slumped Today
    Motley Fool3 months ago

    Why Fiat Chrysler Automobiles, Waters, and Astec Industries Slumped Today

    Despite a strong day for the overall market, bad news for these individual companies hit their shares hard.

  • Waters Corporation (WAT) Q1 2019 Earnings Call Transcript
    Motley Fool3 months ago

    Waters Corporation (WAT) Q1 2019 Earnings Call Transcript

    WAT earnings call for the period ending March 30, 2019.

  • Why Waters Corporation Shares Are Sinking Today
    Motley Fool3 months ago

    Why Waters Corporation Shares Are Sinking Today

    Weaker-than-expected first-quarter earnings results caused the specialty measurement company's stock to slide.

  • Waters' (WAT) Earnings and Revenues Miss Estimates in Q1
    Zacks3 months ago

    Waters' (WAT) Earnings and Revenues Miss Estimates in Q1

    Waters' (WAT) first-quarter 2019 results were negatively impacted by sluggish customer spending and macro-economic headwinds.

  • TheStreet.com3 months ago

    Waters Corp. Drowns Following Earnings Miss

    First-quarter earnings miss analysts' estimates and the company's forecast for the second quarter also is below forecasts.

  • Associated Press3 months ago

    Waters: 1Q Earnings Snapshot

    On a per-share basis, the Milford, Massachusetts-based company said it had net income of $1.51. Earnings, adjusted for one-time gains and costs, came to $1.60 per share. The results did not meet Wall Street ...

  • Business Wire3 months ago

    Waters Corporation (NYSE: WAT) Reports First Quarter 2019 Financial Results

    MILFORD, Mass.-- -- Sales of $514 million declined 3% as reported and were flat in constant currency Recurring revenue growth offset by declines in instrument sales Growth in broader Asia and the U.S. offset by weakness in China and Europe GAAP EPS of $1.51; non-GAAP EPS of $1.60, a slight increase from prior year Waters Corporation today announced first quarter 2019 sales of $514 million, a 3% decrease ...

  • What to Expect From Cypress Semiconductor (CY) Q1 Earnings?
    Zacks3 months ago

    What to Expect From Cypress Semiconductor (CY) Q1 Earnings?

    Cypress Semiconductor's (CY) Q1 earnings are likely to be driven by growth in automotive, IoT and USB-C solutions. However, ongoing trade tension and weak macro environment might impact its results.

  • TE Connectivity (TEL) to Post Q2 Earnings: What's in Store?
    Zacks3 months ago

    TE Connectivity (TEL) to Post Q2 Earnings: What's in Store?

    TE Connectivity's (TEL) industrial and communications solutions portfolio is likely to drive fiscal Q2 results. Weak market conditions in China and softness in European Auto may mar top-line growth.

  • Waters (WAT) to Report Q1 Earnings: What's in the Cards?
    Zacks3 months ago

    Waters (WAT) to Report Q1 Earnings: What's in the Cards?

    Waters' (WAT) first-quarter results are likely to benefit from its well performing segments and end-market momentum.

  • Waters Corporation (NYSE:WAT): Are Analysts Bullish?
    Simply Wall St.3 months ago

    Waters Corporation (NYSE:WAT): Are Analysts Bullish?

    The latest earnings update Waters Corporation (NYSE:WAT) released in December 2018 suggested that the business benefited from a substantial tailwind, more...

  • Memory Weakness to Hurt Lam Research (LRCX) in Q3 Earnings
    Zacks3 months ago

    Memory Weakness to Hurt Lam Research (LRCX) in Q3 Earnings

    Lam Research's (LRCX) fiscal third-quarter results are likely to benefit from strength in non-memory markets. However, memory weakness, PC volatility and increasing competition remain concerns.